These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20152256)

  • 21. Low-dose aspirin and clopidogrel: how to act in patients scheduled for day surgery.
    Servin F
    Curr Opin Anaesthesiol; 2007 Dec; 20(6):531-4. PubMed ID: 17989545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
    Patti G; Di Sciascio G
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding complications related to aspirin dose.
    Laine L; McQuaid K
    Am J Cardiol; 2005 Oct; 96(7):1035-6. PubMed ID: 16188542
    [No Abstract]   [Full Text] [Related]  

  • 24. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 25. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 26. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
    Gulbins H; Malkoc A; Ennker IC; Ennker J
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin as antiplatelet agent in diabetes: Cons.
    Mannucci PM
    Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
    Jähne J; Schirren J
    Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
    [No Abstract]   [Full Text] [Related]  

  • 30. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
    [No Abstract]   [Full Text] [Related]  

  • 31. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
    Hennekens CH; Sechenova O; Hollar D; Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does aspirin reduce recurrence after completing anticoagulant treatment for an idiopathic thromboembolic event?
    Valenzuela A; Aizman A
    Medwave; 2015 Apr; 15(3):e6118. PubMed ID: 25918851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
    Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
    [No Abstract]   [Full Text] [Related]  

  • 35. Aspirin as antiplatelet agent in diabetes. PROS-.
    Davì G; Santilli F
    Eur J Intern Med; 2010 Jun; 21(3):149-53. PubMed ID: 20493412
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of aspirin discontinuation in stable coronary heart disease prior to elective surgery].
    Collet JP
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):652-5. PubMed ID: 12555473
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
    De Caterina R
    Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Sørensen et al.: low dose aspirin.
    Petroski D
    Am J Gastroenterol; 2001 May; 96(5):1646. PubMed ID: 11374720
    [No Abstract]   [Full Text] [Related]  

  • 40. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.